Skip to main content
Erschienen in:

08.01.2022 | Original Article

Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience

verfasst von: Pankaj Kumar Verma, Amit Kumar Rana, Swati Tripathi, Shivesh Kumar, Deepak Upadhyay

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Oral submucous fibrosis is a chronic disease affecting oral cavity and sometimes the pharynx. Etiology seems to be local irritants such as capsaicin, tobacco, areca nut and spicy foods. The main concern in this is the management of trismus and burning sensation of the oral mucosa. The aim of this study was to compare various medical treatment protocol of OSMF. 210 patients were divided randomly in 3 groups. In Group A, patients were given biweekly intralesional Hyaluronidase/Dexamethasone for 6 weeks. Group B patients were given tablet Pentoxifylline 400 mg TDS.Group C patients were given Eprisone hydrochloride. All three groups were given Lycopene 10,000 mcg for period of 6 weeks. All patients were given topical Triamcelone for local application. The examinations for mouth opening were repeated at weekly intervals for a period of 6 weeks.The most common complaint was burning sensation in 75.98% cases, difficulty in mouth opening in77.45% and difficulty in swallowing food in 61.76% cases. Group A showed improvement in 41.17% cases presenting with burning sensation followed by decreased mouth opening 39.70%. Group B showed improvement in 45.58% burning sensation, 17.64% with decreased mouth opening. Group C showed improvement in 48.52% patients having pain with spicy food, 32.35% with decreased mouth opening and 17.64% with difficulty in swallowing. We conclude that patients which received intralesional dexamethasone and hyaluronidase along with oral Lycopene showed better clinical and symptomatic improvement, and at present appears to be best non-surgical treatment.
Literatur
1.
Zurück zum Zitat J Schwartz 1952 Atrophia Idiopathica (tropica) mucosae oris. Demonstrated at the Eleventh International Dental Congress, London, 1952 (cited by Sirsat & Khanolkar) Ind J Med Sci 16 189 197 J Schwartz 1952 Atrophia Idiopathica (tropica) mucosae oris. Demonstrated at the Eleventh International Dental Congress, London, 1952 (cited by Sirsat & Khanolkar) Ind J Med Sci 16 189 197
2.
Zurück zum Zitat SG Joshi 1953 Submucous fibrosis of the palate and pillars Ind J Otolaryngol Head Neck Surg 4 1 4 SG Joshi 1953 Submucous fibrosis of the palate and pillars Ind J Otolaryngol Head Neck Surg 4 1 4
3.
Zurück zum Zitat Anuradha CD, Devi CS (1993) Serum protein, ascorbic acid & iron & tissue collagen in oral submucous fibrosis –a preliminary study. Indian J Med Res 98:147–51 Anuradha CD, Devi CS (1993) Serum protein, ascorbic acid & iron & tissue collagen in oral submucous fibrosis –a preliminary study. Indian J Med Res 98:147–51
4.
Zurück zum Zitat R Rajendran 1994 Oral submucous fibrosis: etiology, pathogenesis, and future research WHO Bull OMS 72 6 985 996 R Rajendran 1994 Oral submucous fibrosis: etiology, pathogenesis, and future research WHO Bull OMS 72 6 985 996
6.
Zurück zum Zitat LK Sharma AK Gupta RD Mukhija P Nigam 1987 Clinical experience with the use of peripheral vasodilator in oral disorders Int J Oral Maxillo Fac Surg 16 6 695 699CrossRef LK Sharma AK Gupta RD Mukhija P Nigam 1987 Clinical experience with the use of peripheral vasodilator in oral disorders Int J Oral Maxillo Fac Surg 16 6 695 699CrossRef
7.
Zurück zum Zitat SS Nichlani MV Jagade A Ganeshan 2011 Benefits of using muscle relaxants in the routine treatment protocol of oral submucosal fibrosis: a pilot study Indian J Otolaryngol Head Neck Surg 63 4 317 320CrossRef SS Nichlani MV Jagade A Ganeshan 2011 Benefits of using muscle relaxants in the routine treatment protocol of oral submucosal fibrosis: a pilot study Indian J Otolaryngol Head Neck Surg 63 4 317 320CrossRef
8.
Zurück zum Zitat R Mehrotra HP Singh SC Gupta M Singh S Jain 2011 Pentoxifylline therapy in the management of oral submucous fibrosis Asian Pac J Cancer Prev 12 4 971 974 R Mehrotra HP Singh SC Gupta M Singh S Jain 2011 Pentoxifylline therapy in the management of oral submucous fibrosis Asian Pac J Cancer Prev 12 4 971 974
9.
Zurück zum Zitat SR Aziz 2009 Lack of reliable evidence for oral submucous fibrosis treatments Evid Based Dent 10 1 8 9CrossRef SR Aziz 2009 Lack of reliable evidence for oral submucous fibrosis treatments Evid Based Dent 10 1 8 9CrossRef
10.
Zurück zum Zitat Gowda BBK, Yathish TR, Sinhasan PS, Naik HK, Somayaji P, Anand D (2011) The response of oral submucous fibrosis to lycopene – a carotenoid antioxidant: a clinicopathological study. J Clin Diag Res 5(4):882–888 Gowda BBK, Yathish TR, Sinhasan PS, Naik HK, Somayaji P, Anand D (2011) The response of oral submucous fibrosis to lycopene – a carotenoid antioxidant: a clinicopathological study. J Clin Diag Res 5(4):882–888
11.
Zurück zum Zitat RM Borle SR Borle 1991 Management of oral; submucous fibrosis: a conservative approach J Oral Maxillofac Surg 49 8 788 791CrossRef RM Borle SR Borle 1991 Management of oral; submucous fibrosis: a conservative approach J Oral Maxillofac Surg 49 8 788 791CrossRef
12.
Zurück zum Zitat N Elizabeth S Gurumani GA Bala George Tukalan 2014 A comparative study between management of oral submucous fibrosis J Evolut Med Dental Sci 3 47 11344 48CrossRef N Elizabeth S Gurumani GA Bala George Tukalan 2014 A comparative study between management of oral submucous fibrosis J Evolut Med Dental Sci 3 47 11344 48CrossRef
13.
Zurück zum Zitat S Goel J Ahmed MP Singh P Nahar 2010 Oral submucous fibrosis: a clinico-histopthological comparative study in population of Southern Rajasthan J Carcinogenesis Mutagenesis 1 108CrossRef S Goel J Ahmed MP Singh P Nahar 2010 Oral submucous fibrosis: a clinico-histopthological comparative study in population of Southern Rajasthan J Carcinogenesis Mutagenesis 1 108CrossRef
14.
Zurück zum Zitat JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654CrossRef JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654CrossRef
15.
Zurück zum Zitat PA Hayes 1985 Oral submucous fibrosis in a 4-year-old girl Oral Surg Oral Med Oral Pathol 59 5 475 478CrossRef PA Hayes 1985 Oral submucous fibrosis in a 4-year-old girl Oral Surg Oral Med Oral Pathol 59 5 475 478CrossRef
16.
Zurück zum Zitat PN Sinor PC Gupta PR Murti RB Bhonsle DK Daftary FS Mehta 1990 A case control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut J Oral Pathol Med 19 2 94 98CrossRef PN Sinor PC Gupta PR Murti RB Bhonsle DK Daftary FS Mehta 1990 A case control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut J Oral Pathol Med 19 2 94 98CrossRef
17.
Zurück zum Zitat PV Vanaja Reddy NR Wanjari PR Banda 2011 Oral submucous fibrosis: correlation of clinical grading to various habit factors Int J Dent Clin 3 21 24 PV Vanaja Reddy NR Wanjari PR Banda 2011 Oral submucous fibrosis: correlation of clinical grading to various habit factors Int J Dent Clin 3 21 24
18.
Zurück zum Zitat RB Bhonsle PR Murti DK Daftary PC Gupta FS Mehta PN Sinor 1987 Regional variations in oral submucous fibrosis in India Commun Dent Oral Epidemiol 15 4 225 229CrossRef RB Bhonsle PR Murti DK Daftary PC Gupta FS Mehta PN Sinor 1987 Regional variations in oral submucous fibrosis in India Commun Dent Oral Epidemiol 15 4 225 229CrossRef
19.
Zurück zum Zitat Gaur SK, Sinha ON, Madan J (2013) A study and evaluation of various modalities of non-surgical treatment in oral submucous fibrosis. Int J Institut Pharm Life Sci 3(5):1–4 Gaur SK, Sinha ON, Madan J (2013) A study and evaluation of various modalities of non-surgical treatment in oral submucous fibrosis. Int J Institut Pharm Life Sci 3(5):1–4
20.
Zurück zum Zitat A Auluck MP Rosin L Zhang KN Sumanth 2008 Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature J Can Dent Assoc 74 8 735 740 A Auluck MP Rosin L Zhang KN Sumanth 2008 Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature J Can Dent Assoc 74 8 735 740
21.
Zurück zum Zitat JC Paymaster 1956 Cancer of the buccal mucosa. A clinical study in 650 cases in Indian patients Cancer 9 3 431 5CrossRef JC Paymaster 1956 Cancer of the buccal mucosa. A clinical study in 650 cases in Indian patients Cancer 9 3 431 5CrossRef
22.
Zurück zum Zitat PN Wahi VL Kapur UK Luthra MC Srivastava 1966 Submucous fibrosis of the oral cavity: histomorphological studies Br J Cancer 20 676 687CrossRef PN Wahi VL Kapur UK Luthra MC Srivastava 1966 Submucous fibrosis of the oral cavity: histomorphological studies Br J Cancer 20 676 687CrossRef
23.
Zurück zum Zitat JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654CrossRef JJ Pindborg FS Mehta PC Gupta DK Daftary 1968 Prevalance of oral submucous fibrosis among 50,915 Indian villagers Br J Cancer 22 4 646 654CrossRef
24.
Zurück zum Zitat NP Selvam AA Dayanand 2013 Lycopene in the management of oral submucous fibrosis Asian J Pharm Clin Res 6 3 58 61 NP Selvam AA Dayanand 2013 Lycopene in the management of oral submucous fibrosis Asian J Pharm Clin Res 6 3 58 61
25.
Zurück zum Zitat PK Kakar RK Puri VP Venkatachalam 1985 Oral submucous fibrosis-treatment with hylase J Laryngolotol 99 1 57 59CrossRef PK Kakar RK Puri VP Venkatachalam 1985 Oral submucous fibrosis-treatment with hylase J Laryngolotol 99 1 57 59CrossRef
26.
Zurück zum Zitat L James A Shetty D Rishi M Abraham 2015 Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in grade III oral submucous fibrosis: a retrospective study J Int Oral Health 7 8 1 4 L James A Shetty D Rishi M Abraham 2015 Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in grade III oral submucous fibrosis: a retrospective study J Int Oral Health 7 8 1 4
27.
Zurück zum Zitat Gupta J, Srinivasan SV, Jonathan Daniel M (2012) Efficacy of betamethasone, placental extract and hyaluronidase in the treatment of osmf: a comparative study. e-J. Dent 2(1):132–135 Gupta J, Srinivasan SV, Jonathan Daniel M (2012) Efficacy of betamethasone, placental extract and hyaluronidase in the treatment of osmf: a comparative study. e-J. Dent 2(1):132–135
28.
Zurück zum Zitat D Singh MC Shashikanth N Misra S Agrawal 2014 Lycopene and intralesional betamethasone injections in the management of oral submucous fibrosis J Indian Acad Oral Med Radiol 26 264 268CrossRef D Singh MC Shashikanth N Misra S Agrawal 2014 Lycopene and intralesional betamethasone injections in the management of oral submucous fibrosis J Indian Acad Oral Med Radiol 26 264 268CrossRef
29.
Zurück zum Zitat R Rajendran V Rani S Shaikh 2006 Pentoxifylline therapy : a new adjunct in the treatment of oral submucous fibrosis Indian J Dent Res 17 190 198CrossRef R Rajendran V Rani S Shaikh 2006 Pentoxifylline therapy : a new adjunct in the treatment of oral submucous fibrosis Indian J Dent Res 17 190 198CrossRef
30.
Zurück zum Zitat BJ Chetan UR Hemant K Shah H Valimaa 2013 Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis Clin Oral Investig 17 5 1375 1382CrossRef BJ Chetan UR Hemant K Shah H Valimaa 2013 Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis Clin Oral Investig 17 5 1375 1382CrossRef
31.
Zurück zum Zitat S Patil MG Sghaireen S Maheshwari SR Kunsi R Sahu 2015 Comparative study of the efficacy of Lycopene and Aloe Vera in the treatment of oral submucous fibrosis Int J Health Allied Sci 4 13 17CrossRef S Patil MG Sghaireen S Maheshwari SR Kunsi R Sahu 2015 Comparative study of the efficacy of Lycopene and Aloe Vera in the treatment of oral submucous fibrosis Int J Health Allied Sci 4 13 17CrossRef
32.
Zurück zum Zitat M Singh HS Niranjan R Mehrotra D Shrama SC Gupta 2010 Efficacy of hydrocortisone acetate/hyluronidase vs trimcinoloneacetonide/hyaluronidase in the treatment of oral submucous fibrosis Indian J Med Res 131 665 M Singh HS Niranjan R Mehrotra D Shrama SC Gupta 2010 Efficacy of hydrocortisone acetate/hyluronidase vs trimcinoloneacetonide/hyaluronidase in the treatment of oral submucous fibrosis Indian J Med Res 131 665
Metadaten
Titel
Evaluation of Clinical Profile and Various Treatment Modalities in Oral Sub Mucous Fibrosis in North India: Our Experience
verfasst von
Pankaj Kumar Verma
Amit Kumar Rana
Swati Tripathi
Shivesh Kumar
Deepak Upadhyay
Publikationsdatum
08.01.2022
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 3/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-021-03049-y

Neu im Fachgebiet HNO

Obstruktive Schlafapnoe: Das steht abseits von CPAP auf dem Plan

Die obstruktive Schlafapnoe kann durch verschiedene Verfahren behandelt werden wie Lagetherapie und chirurgische Interventionen. Eine medikamentöse Therapie kommt zwar (noch) nicht infrage. Auf dem Pneumologie-Kongress wurden aber erste vielversprechende Ansätze präsentiert. 

Lösten In-Ear-Kopfhörer den Lagerungsschwindel aus?

Ein 43-jähriger Patient stellt sich wegen Anfällen von Drehschwindel in der Notaufnahme vor. Diese kämen immer nur dann, wenn er zuvor Musik über Kopfhörer gehört habe. Könnte ein Zusammenhang bestehen?

Weniger Bargeld, weniger Erstickungsnotfälle?

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Wer schlechter riechen kann, stirbt früher

Ein eingeschränkter Geruchssinn scheint bei Älteren mit einer höheren Gesamtsterblichkeit einherzugehen. Dafür sprechen Längsschnittdaten aus Stockholm. Besonders bedeutsam sind dabei wohl Zusammenhänge mit Gebrechlichkeit und Neurodegeneration.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.